What Research Tells Us About Aspirin and Covid-19
In a new story for Elemental, Markham Heid reports on the idea that aspirin may turn out to be a cheap and effective way to save lives and prevent lasting damage. He reports:
For a study published on October 21 in the journal Anesthesia and Analgesia, Chow and Mazzeffi — along with a multi-university team of researchers — examined the effects of aspirin among people hospitalized with Covid-19. After adjusting their data to account for age, BMI, race, preexisting conditions, and other variables that could muddy their conclusions, they determined that the risk of death or ICU admission was almost halved among people who got aspirin compared to those who did not.
“This is now the second study linking blood thinners of some kind with improved outcomes,” Mazzeffi says. “I think it’s driving home the point that an important part of the disease’s process is clotting in the organs and that intervening in those pathways is something we should focus on.”
Read the full story below.
